In situ pneumococcal vaccine production and delivery through a hybrid biological-biomaterial vector

Science Advances

Volumn 2, Issue 7, 2016, Pages

  Li, Yi ^a   Beitelshees, Marie ^a   Fang, Lei ^a   Hill, Andrew ^b   Ahmadi, Mahmoud Kamal ^a   Chen, Mingfu ^a   Davidson, Bruce A ^c   Knight, Paul ^c   Smith, Randall J ^d   Andreadis, Stelios T ^a,d,e   Hakansson, Anders P ^c,f   Jones, Charles H ^a,b   Pfeifer, Blaine A ^a,b  

^a State University of New York ^*  (United States)

^b Abcombi Biosciences Inc   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d The State University of New York   (United States)

^e UNIVERSITY AT BUFFALO   (United States)

^f LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS; BACTERIA; ENZYME ACTIVITY; IMMUNE SYSTEM; VACCINES; VECTORS;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELLS; DESIGN AND IMPLEMENTATIONS; DISEASE PREVENTION; IMMUNOLOGICAL RESPONSE; INTRACELLULAR DELIVERY; STREPTOCOCCUS PNEUMONIAE; VACCINE PRODUCTION;

DISEASES;

BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BIOMATERIAL; IMMUNOLOGICAL ADJUVANT; PNEUMOCOCCUS VACCINE; POLY(BETA-AMINO ESTER); POLYMER; RECOMBINANT VACCINE;

ANIMAL; CHEMISTRY; DISEASE MODEL; FEMALE; GENETICS; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MOUSE; NASOPHARYNX; PATHOGENICITY; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE; VETERINARY;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BIOCOMPATIBLE MATERIALS; DISEASE MODELS, ANIMAL; FEMALE; MICE; NASOPHARYNX; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; POLYMERS; STREPTOCOCCUS PNEUMONIAE; VACCINES, SYNTHETIC;

EID: 84980487971     PISSN: None     EISSN: 23752548     Source Type: Journal    
DOI: 10.1126/sciadv.1600264     Document Type: Article

References (23)

1. S. A. Plotkin, Vaccines: Past, present and future. Nat. Med. 11, S5–S11 (2005).
2. C. H. Jones, C.-K. Chen, A. Ravikrishnan, S. Rane, B. A. Pfeifer, Overcoming nonviral gene delivery barriers: Perspective and future. Mol. Pharm. 10, 4082–4098 (2013).
3. C. H. Jones, A. Ravikrishnan, M. Chen, R. Reddinger, M. K. Ahmadi, S. Rane, A. P. Hakansson, B. A. Pfeifer, Hybrid biosynthetic gene therapy vector development and dual engineering capacity. Proc. Natl. Acad. Sci. U.S.A. 111, 12360–12365 (2014).
4. C. H. Jones, M. Chen, A. Ravikrishnan, R. Reddinger, G. Zhang, A. P. Hakansson, B. A. Pfeifer, Mannosylated poly(beta-amino esters) for targeted antigen presenting cell immune modulation. Biomaterials 37, 333–344 (2014).
5. L. O. Bakaletz, Bacterial biofilms in the upper airway - evidence for role in pathology and implications for treatment of otitis media. Paediatr. Respir. Rev. 13, 154–159 (2012).
6. W. P. Hausdorff, B. Hoet, R. A. Adegbola, Predicting the impact of new pneumococcal conjugate vaccines: Serotype composition is not enough. Expert Rev. Vaccines 14, 413–428 (2015).
7. K. L. O’Brien, L. J. Wolfson, J. P. Watt, E. Henkle, M. Deloria-Knoll, N. McCall, E. Lee, K. Mulholland, O. S. Levine, T. Cherian; Hib and Pneumococcal Global Burden of Disease Study Team, Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: Global estimates. Lancet 374, 893–902 (2009).
8. H. Roche, A. Håkansson, S. K. Hollingshead, D. E. Briles, Regions of PspA/EF3296 best able to elicit protection against Streptococcus pneumoniae in a murine infection model. Infect. Immun. 71, 1033–1041 (2003).
9. H. Roche, B. Ren, L. S. McDaniel, A. Håkansson, D. E. Briles, Relative roles of genetic background and variation in PspA in the ability of antibodies to PspA to protect against capsular type 3 and 4 strains of Streptococcus pneumoniae. Infect. Immun. 71, 4498–4505 (2003).
10. T.-C. Chung, C. H. Jones, A. Gollakota, M. K. Ahmadi, S. Rane, G. Zhang, B. A. Pfeifer, Improved Escherichia coli bactofection and cytotoxicity by heterologous expression of bacteriophage FX174 lysis gene E. Mol. Pharm. 12, 1691–1700 (2015).
11. M. M. Pettigrew, L. R. Marks, Y. Kong, J. F. Gent, H. Roche-Hakansson, A. P. Hakansson, Dynamic changes in the Streptococcus pneumoniae transcriptome during transition from biofilm formation to invasive disease upon influenza a virus infection. Infect. Immun. 82, 4607–4619 (2014).
12. L. R. Marks, G. I. Parameswaran, A. P. Hakansson, Pneumococcal interactions with epithelial cells are crucial for optimal biofilm formation and colonization in vitro and in vivo. Infect. Immun. 80, 2744–2760 (2012).
13. L. R. Marks, B. A. Davidson, P. R. Knight, A. P. Hakansson, Interkingdom signaling induces Streptococcus pneumoniae biofilm dispersion and transition from asymptomatic colonization to disease. mBio 4, e00438-13 (2013).
14. T. Chonmaitree, V. M. Howie, A. L. Truant, Presence of respiratory viruses in middle ear fluids and nasal wash specimens from children with acute otitis media. Pediatrics 77, 698–702 (1986).
15. M. M. Pettigrew, J. F. Gent, R. B. Pyles, A. L. Miller, J. Nokso-Koivisto, T. Chonmaitree, Viral-bacterial interactions and risk of acute otitis media complicating upper respiratory tract infection. J. Clin. Microbiol. 49, 3750–3755 (2011).
16. H. Zhang, Y. Wang, J. Wu, K. Skalina, B. A. Pfeifer, Complete biosynthesis of erythromycin A and designed analogs using E. coli as a heterologous host. Chem. Biol. 17, 1232–1240 (2010).
17. R. Rappuoli, Bridging the knowledge gaps in vaccine design. Nat. Biotechnol. 25, 1361–1366 (2007).
18. C. H. Jones, A. Gollakota, M. Chen, T.-C. Chung, A. Ravikrishnan, G. Zhang, B. A. Pfeifer, Influence of molecular weight upon mannosylated bio-synthetic hybrids for targeted antigen presenting cell gene delivery. Biomaterials 58, 103–111 (2015).
19. C. H. Jones, M. Chen, A. Gollakota, A. Ravikrishnan, G. Zhang, S. Lin, M. Tan, C. Cheng, H. Lin, B. A. Pfeifer, Structure–function assessment of mannosylated poly(b-amino esters) upon targeted antigen presenting cell gene delivery. Biomacromolecules 16, 1534–1541 (2015).
20. D. E. Briles, E. Ades, J. C. Paton, J. S. Sampson, G M. Carlone, R. C. Hueber, A. Virolainen, E. Swiatlo, S. K. Hollingshead, Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae. Infect. Immun. 68, 796–800 (2000).
21. R. E. Tyx, H. Roche-Hakansson, A. P. Hakansson, Role of dihydrolipoamide dehydrogenase in regulation of raffinose transport in Streptococcus pneumoniae. J. Bacteriol. 193, 3512–3524 (2011).
22. B. A. Davidson, R. R. Vethanayagam, M. J. Grimm, B. A. Mullan, K. Raghavendran, T. S. Blackwell, M. L. Freeman, V. Ayyasamy, K. K. Singh, M. B. Sporn, K. Itagaki, C. J. Hauser, P. R. Knight, B. H. Segal, NADPH oxidase and Nrf2 regulate gastric aspiration–induced inflammation and acute lung injury. J. Immunol. 190, 1714–1724 (2013).
23. K. E. Stevens, M. E. Sebert, Frequent beneficial mutations during single-colony serial transfer of Streptococcus pneumoniae. PLOS Genet. 7, e1002232 (2011).